REQUEST A DEMO
Total
USD $0.00
Search more companies

Unilabs Pathology K.S. (Czech Republic)

Main Activities: Outpatient Care Centers | Medical Laboratories | All Other Ambulatory Health Care Services
Full name: Unilabs Pathology K.S. Profile Updated: September 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Unilabs Pathology K.S. is a company based in Czech Republic, with its head office in Prague. The enterprise operates in the Outpatient Care Centers industry. It was first established on September 15, 1993. It currently has a total number of 200 - 249 (2023) employees. From the latest financial highlights, Unilabs Pathology K.S. reported a net sales revenue increase of 1.09% in 2025. Its’ total assets recorded a growth of 7.1%. Unilabs Pathology K.S.’s net profit margin decreased by 0.08% in 2025.

Headquarters
Evropska 2589/33
Prague; The City of Prague; Postal Code: 16000

Contact Details: Purchase the Unilabs Pathology K.S. report to view the information.

Website: https://www.unilabs.cz/cs/laboratore/patologie/AeskuLab-Brno

Basic Information
Total Employees:
Purchase the Unilabs Pathology K.S. report to view the information.
Financial Auditors:
Purchase the Unilabs Pathology K.S. report to view the information.
Incorporation Date:
September 15, 1993
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Subsidiaries
Centrum Onkologicke Prevence Pro Zeny, S.R.O. V Likvidaci
100%
Company Performance
Financial values in the chart are available after Unilabs Pathology K.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
1.09%
Total Operating Revenue
1.39%
Operating Profit
-30.26%
EBITDA
-28.05%
Net Profit/Loss for the Period
-26.13%
Total Assets
7.1%
Total Equity
4.16%
Operating Profit Margin
-12.05%
Net Profit Margin
-0.08%
Return on Equity (ROE)
-1.64%
Quick Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?